Certara, Inc. (NASDAQ:CERT) Receives Average Recommendation of "Hold" from Analysts

Shares of Certara, Inc. (NASDAQ:CERT - Get Free Report) have been assigned a consensus recommendation of "Hold" from the eight research firms that are currently covering the firm, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $15.92.

CERT has been the subject of several recent research reports. Barclays dropped their price objective on Certara from $14.00 to $12.00 and set an "equal weight" rating for the company in a report on Thursday, November 7th. UBS Group raised shares of Certara from a "neutral" rating to a "buy" rating and set a $16.00 price target for the company in a research note on Friday, September 27th. Finally, Robert W. Baird reduced their price objective on shares of Certara from $18.00 to $13.00 and set a "neutral" rating on the stock in a research note on Tuesday, November 5th.

Insider Buying and Selling

In other news, insider Patrick F. Smith sold 5,409 shares of the stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $11.03, for a total value of $59,661.27. Following the completion of the sale, the insider now owns 50,091 shares of the company's stock, valued at approximately $552,503.73. This represents a 9.75 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Leif E. Pedersen sold 51,224 shares of the business's stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $11.29, for a total transaction of $578,318.96. Following the completion of the sale, the insider now directly owns 99,704 shares of the company's stock, valued at approximately $1,125,658.16. The trade was a 33.94 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.39% of the company's stock.

Institutional Investors Weigh In On Certara

Several institutional investors have recently made changes to their positions in the stock. Brown Brothers Harriman & Co. acquired a new position in Certara in the 3rd quarter valued at $27,292,000. Sei Investments Co. lifted its holdings in shares of Certara by 39.5% during the 2nd quarter. Sei Investments Co. now owns 997,871 shares of the company's stock worth $13,821,000 after acquiring an additional 282,357 shares during the period. Massachusetts Financial Services Co. MA lifted its holdings in shares of Certara by 40.7% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,901,898 shares of the company's stock worth $45,691,000 after acquiring an additional 1,128,006 shares during the period. Daventry Group LP boosted its position in shares of Certara by 153.0% during the 2nd quarter. Daventry Group LP now owns 1,308,572 shares of the company's stock worth $18,124,000 after acquiring an additional 791,405 shares in the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC increased its stake in shares of Certara by 8.4% in the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 810,206 shares of the company's stock valued at $11,221,000 after purchasing an additional 62,912 shares during the last quarter. 73.96% of the stock is currently owned by institutional investors.

Certara Price Performance

Shares of CERT stock traded up $0.19 during trading hours on Friday, reaching $10.85. 1,145,965 shares of the company were exchanged, compared to its average volume of 820,665. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.86 and a quick ratio of 2.86. The company has a market cap of $1.75 billion, a price-to-earnings ratio of -53.30, a P/E/G ratio of 5.70 and a beta of 1.53. The stock's fifty day moving average is $10.84 and its two-hundred day moving average is $12.88. Certara has a fifty-two week low of $9.41 and a fifty-two week high of $19.87.

Certara (NASDAQ:CERT - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.02. The firm had revenue of $94.80 million for the quarter, compared to the consensus estimate of $95.51 million. Certara had a positive return on equity of 3.43% and a negative net margin of 8.34%. The business's revenue for the quarter was up 10.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.06 EPS. Sell-side analysts forecast that Certara will post 0.28 earnings per share for the current fiscal year.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.